UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 162 filers reported holding UNIQURE NV in Q3 2020. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $8,547,000 | -14.2% | 270,400 | +28.8% | 1.73% | -34.6% |
| Q1 2020 | $9,965,000 | -33.8% | 210,000 | 0.0% | 2.64% | -10.6% |
| Q4 2019 | $15,049,000 | +86.5% | 210,000 | +2.4% | 2.95% | +1.2% |
| Q3 2019 | $8,069,000 | -49.6% | 205,000 | 0.0% | 2.92% | -40.2% |
| Q2 2019 | $16,021,000 | +31.0% | 205,000 | 0.0% | 4.88% | +44.2% |
| Q1 2019 | $12,228,000 | +587.7% | 205,000 | +125.8% | 3.39% | +495.1% |
| Q4 2017 | $1,778,000 | – | 90,801 | – | 0.57% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 841,471 | $15,786,000 | 5.69% |
| Nantahala Capital Management | 2,901,929 | $54,440,000 | 3.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 544,500 | $10,209,000 | 3.27% |
| 683 Capital Management, LLC | 1,373,600 | $25,768,000 | 1.99% |
| PFM Health Sciences, LP | 2,393,311 | $44,899,000 | 1.62% |
| Integral Health Asset Management, LLC | 433,000 | $8,123,000 | 1.58% |
| Privium Fund Management B.V. | 238,998 | $4,283,000 | 1.56% |
| Nantahala Capital Management | 1,000,000 | $18,760,000 | 1.21% |
| Henry James International Management Inc. | 89,469 | $1,678,000 | 0.94% |
| Altium Capital Management LP | 105,000 | $1,970,000 | 0.72% |